Streetbeat News

Revenues

JANX

Janux Therapeutics (NASDAQ:JANX) received mixed analyst ratings with an updated average 12-month price target of $62.75, marking a significant increase from the previous $27.67. Analysts from Cantor Fitzgerald, B of A Securities, HC Wainwright & Co., and Wedbush have updated their ratings and price targets, reflecting a positive outlook on the company's future. Despite a recent decline in revenue growth and a market capitalization below industry benchmarks, Janux Therapeutics demonstrates strong profitability metrics such as net margin, ROE, and ROA, with a low debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

March 20, 2024 | 2:00 pm

NVO

Novo Nordisk (NYSE:NVO) received seven somewhat bullish analyst ratings in the last quarter, with a notable increase in the 12-month price target to $142.86 from $130.00, indicating a 9.89% rise. Analysts from firms like Cantor Fitzgerald and Morgan Stanley have maintained or raised their overweight ratings, reflecting positive expectations for the company's performance. Novo Nordisk, a leader in diabetes care, has shown strong financial health with a revenue growth of 36.95%, a net margin of 33.35%, and an ROE of 22.01%, outperforming industry averages.

Portfolio Pulse from Benzinga Insights

March 20, 2024 | 2:00 pm

MODG

Topgolf Callaway Brands Corp (NYSE:MODG) shares are rising following a report that the company is considering a sale, with a South Korean strategic investor potentially acquiring it for about $2.98 billion. This comes as TopGolf Callaway's market cap was approximately $2.64 billion as of the last close. The company plans to sell Callaway Golf and spin off its TopGolf subsidiary. Additionally, Topgolf Callaway's revenue has grown at an average rate of 31.33% annually over the past five years, with an average one-year price target from analysts at $17, indicating a 9.11% expected upside in 2025.

Portfolio Pulse from Adam Eckert

March 20, 2024 | 1:47 pm

UAL

United Airlines Holdings (NASDAQ:UAL) received mixed analyst ratings over the past three months, with a total of 5 analysts providing insights. The recent evaluations show a shift towards a more neutral stance compared to previous months. The average 12-month price target for UAL is now $55.6, marking a 13.47% increase from the previous target of $49.00. Analysts from firms including UBS, Redburn Atlantic, Evercore ISI Group, Susquehanna, and B of A Securities have updated their ratings and price targets, reflecting changes in market conditions and company performance. United Airlines has shown strong financial health with a notable revenue growth rate of 9.89%, a net margin of 4.4%, and an ROE of 6.59%, outperforming industry averages.

Portfolio Pulse from Benzinga Insights

March 20, 2024 | 1:01 pm

NEWT

Recent analyst reviews of NewtekOne (NASDAQ:NEWT) show a mix of ratings, with a shift towards a more cautious outlook. The average 12-month price target has been lowered to $14.5, indicating a 10.77% decrease from the previous target of $16.25. Analysts from firms like Keefe, Bruyette & Woods, Piper Sandler, and B. Riley Securities have adjusted their price targets and ratings, reflecting changes in market conditions and NewtekOne's performance. Despite the market cap being below industry average, NewtekOne has shown significant revenue growth, a high net margin, and strong ROE and ROA, but concerns about its high debt-to-equity ratio persist.

Portfolio Pulse from Benzinga Insights

March 20, 2024 | 1:00 pm

ARMK

Aramark (NYSE:ARMK) received mixed analyst ratings over the past three months, with a recent shift towards a more bullish outlook. The average 12-month price target for Aramark has been raised to $33.5, indicating a 4.69% increase from the previous target. Analysts from firms including Truist Securities, Morgan Stanley, RBC Capital, and Goldman Sachs have adjusted their ratings and price targets, reflecting changes in market conditions and Aramark's performance. Despite positive revenue growth, Aramark faces challenges in profitability, efficiency, and debt management compared to industry benchmarks.

Portfolio Pulse from Benzinga Insights

March 20, 2024 | 1:00 pm

IFF

Analysts have provided mixed reviews for Intl Flavors & Fragrances (IFF) with a recent shift towards a more neutral stance. The average 12-month price target has been raised to $85.91, indicating a positive outlook. Despite this, IFF faces financial challenges, including a revenue decline of -4.96% and a net margin of -96.45%, suggesting difficulties in profitability and asset utilization.

Portfolio Pulse from Benzinga Insights

March 20, 2024 | 1:00 pm

NCMI

National CineMedia (NASDAQ:NCMI) received mixed analyst ratings over the past three months, with a shift towards a more bullish outlook in the last 30 days. The average 12-month price target for NCMI has increased by 26.44% to $5.69, with a high estimate of $6.75 and a low of $4.50. Analysts from Benchmark, Wedbush, and B. Riley Securities have updated their ratings and price targets, reflecting dynamic market conditions and company performance. National CineMedia operates a digital in-theatre media network in North America, facing challenges in revenue growth but excelling in net margin, ROE, and ROA.

Portfolio Pulse from Benzinga Insights

March 20, 2024 | 1:00 pm

DHE

ITB

LEN

February saw a rebound in housing starts, with a 10.7% increase to an annualized rate of 1.521 million, surpassing forecasts. Building permits also rose by 1.9%. Despite high interest rates affecting affordability, the housing market shows resilience with stable demand and a shortage of existing homes for sale. The iShares U.S. Home Construction ETF (ITB) has gained 78% since the beginning of 2023 but dipped 1.6% since March. D.R. Horton Inc (DHE) remains flat year-to-date, while Lennar Corporation (LEN) is up 5% despite recent drops.

Portfolio Pulse from Neil Dennis

March 20, 2024 | 12:56 pm

FANH

Fanhua Inc. reported its Q4 total revenues at $85.0M, marking a 21.4% decrease compared to the same period last year. The company also reported an adjusted earnings per ADS of $(0.07).

Portfolio Pulse from Benzinga Newsdesk

March 20, 2024 | 12:52 pm